Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein Interaction

被引：4

作者：

Jha, Ram ^{[1
,2
]}

Kinna, Alexander ^{[1
]}

Hotblack, Alastair ^{[2
]}

Bughda, Reyisa ^{[1
]}

Bulek, Anna ^{[1
]}

Gannon, Isaac ^{[1
]}

Ilca, Tudor ^{[1
]}

Allen, Christopher ^{[1
]}

Lamb, Katarina ^{[1
]}

Dolor, Abigail ^{[1
]}

Scott, Ian ^{[1
]}

Parekh, Farhaan ^{[1
]}

Sillibourne, James ^{[1
]}

Cordoba, Shaun ^{[1
]}

Onuoha, Shimobi ^{[1
]}

Thomas, Simon ^{[1
]}

Ferrari, Mathieu ^{[1
]}

Pule, Martin ^{[1
,2
]}

机构：

[1] Autolus Therapeut, London W12 7FP, England

[2] UCL, UCL Canc Inst, Res Dept Haematol, London WC1E 6DD, England

来源：

ACS CHEMICAL BIOLOGY | 2024年 / 19卷 / 02期

关键词：

SINGLE-DOMAIN ANTIBODIES; CAR T-CELLS; TET REPRESSOR; RAPAMYCIN; SELECTION; AFFINITY; BINDING; SAFETY; LIBRARIES; DISPLAY;

D O I：

10.1021/acschembio.3c00521

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A versatile, safe, and effective small-molecule control system is highly desirable for clinical cell therapy applications. Therefore, we developed a two-component small-molecule control system based on the disruption of protein-protein interactions using minocycline, an FDA-approved antibiotic with wide availability, excellent biodistribution, and low toxicity. The system comprises an anti-minocycline single-domain antibody (sdAb) and a minocycline-displaceable cyclic peptide. Here, we show how this versatile system can be applied to OFF-switch split CAR systems (MinoCAR) and universal CAR adaptors (MinoUniCAR) with reversible, transient, and dose-dependent suppression; to a tunable T cell activation module based on MyD88/CD40 signaling; to a controllable cellular payload secretion system based on IL12 KDEL retention; and as a cell/cell inducible junction. This work represents an important step forward in the development of a remote-controlled system to precisely control the timing, intensity, and safety of therapeutic interventions.

引用

页码：308 / 324

页数：17

共 73 条

[1] Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines [J].

Agwuh, Kenneth N. ;

MacGowan, Alasdair .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) :256-265

[2] Therapeutic cancer targeting peptides [J].

Aina, OH ;

Sroka, TC ;

Chen, ML ;

Lam, KS .

BIOPOLYMERS, 2002, 66 (03) :184-199

[3] Heat-induced Irreversible Denaturation of the Camelid Single Domain VHH Antibody Is Governed by Chemical Modifications [J].

Akazawa-Ogawa, Yoko ;

Takashima, Mizuki ;

Lee, Young-Ho ;

Ikegami, Takahisa ;

Goto, Yuji ;

Uegaki, Koichi ;

Hagihara, Yoshihisa .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (22) :15666-15679

[4] Generation of llama single-domain antibodies against methotrexate, a prototypical hapten [J].

Alvarez-Rueda, Nidia ;

Behar, Ghislaine ;

Ferre, Virginie ;

Pugniere, Martine ;

Roquet, Francoise ;

Gastinel, Louis ;

Jacquot, Catherine ;

Aubry, Jacques ;

Baty, Daniel ;

Barbet, Jacques ;

Birkle, Stephane .

MOLECULAR IMMUNOLOGY, 2007, 44 (07) :1680-1690

[5]

Bachmann M., 2016, Universal Chimeric Antigen Receptor Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders, Patent No. 2016030414

[6] Characterization of the FKBP•Rapamycin•FRB ternary complex [J].

Banaszynski, LA ;

Liu, CW ;

Wandless, TJ .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (13) :4715-4721

[7] Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity [J].

Bayle, JH ;

Grimley, JS ;

Stankunas, K ;

Gestwicki, JE ;

Wandless, TJ ;

Crabtree, GR .

CHEMISTRY & BIOLOGY, 2006, 13 (01) :99-107

[8] Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study [J].

Berdeja, Jesus G. ;

Madduri, Deepu ;

Usmani, Saad Z. ;

Jakubowiak, Andrzej ;

Agha, Mounzer ;

Cohen, Adam D. ;

Stewart, A. Keith ;

Hari, Parameswaran ;

Htut, Myo ;

Lesokhin, Alexander ;

Deol, Abhinav ;

Munshi, Nikhil C. ;

O'Donnell, Elizabeth ;

Avigan, David ;

Singh, Indrajeet ;

Zudaire, Enrique ;

Yeh, Tzu-Min ;

Allred, Alicia J. ;

Olyslager, Yunsi ;

Banerjee, Arnob ;

Jackson, Carolyn C. ;

Goldberg, Jenna D. ;

Schecter, Jordan M. ;

Deraedt, William ;

Zhuang, Sen Hong ;

Infante, Jeffrey ;

Geng, Dong ;

Wu, Xiaoling ;

Carrasco-Alfonso, Marlene J. ;

Akram, Muhammad ;

Hossain, Farah ;

Rizvi, Syed ;

Fan, Frank ;

Lin, Yi ;

Martin, Thomas ;

Jagannath, Sundar .

LANCET, 2021, 398 (10297) :314-324

[9] Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation [J].

Berger, C ;

Flowers, ME ;

Warren, EH ;

Riddell, SR .

BLOOD, 2006, 107 (06) :2294-2302

[10] Purity by design: Reducing impurities in bioproduction by stimulus-controlled global translational downregulation of non-product proteins [J].

Bojar, Daniel ;

Fuhrer, Tobias ;

Fussenegger, Martin .

METABOLIC ENGINEERING, 2019, 52 :110-123

← 1 2 3 4 5 6 7 8 →